본문 바로가기
KERD
논문KCI 등재

Dissecting the MUC5AC/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma

Chaudhary Sanjib|Siddiqui Jawed Akhtar|Appadurai Muthamil Iniyan|Maurya Shailendra Kumar|Murakonda Swathi P.|Blowers Elizabeth|Swanson Ben J.|Nasser Mohd Wasim|Batra Surinder K.|Lakshmanan Imayavaramban|Ganti Apar Kishor
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2024.12|Experimental and Molecular Medicine|제56권 |pp. 1-11|DOI 10.1038/s12276-024-01255-6

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Non-small cell lung carcinoma (NSCLC) exhibits a heightened propensity for brain metastasis, posing a significant clinical challenge. Mucin 5ac (MUC5AC) plays a pivotal role in the development of lung adenocarcinoma (LUAD); however, its role in causing brain metastases remains unknown. In this study, we aimed to investigate the contribution of MUC5AC to brain metastasis in patients with LUAD utilizing various brain metastasis models. Our findings revealed a substantial increase in the MUC5AC level in LUAD brain metastases (LUAD-BrM) samples and brain-tropic cell lines compared to primary samples or parental control cell lines. Intriguingly, depletion of MUC5AC in brain-tropic cells led to significant reductions in intracranial metastasis and tumor growth, and improved survival following intracardiac injection, in contrast to the observations in the control groups. Proteomic analysis revealed that mechanistically, MUC5AC depletion resulted in decreased expression of metastasis-associated molecules. There were increases in epithelial-to-mesenchymal transition, tumor invasiveness, and metastasis phenotypes in tumors with high MUC5AC expression. Furthermore, immunoprecipitation and proteomic analysis revealed a novel interaction of MUC5AC with Annexin A2 (ANXA2), which activated downstream matrix metalloproteases and facilitated extracellular matrix degradation to promote metastasis. Disrupting MUC5AC-ANXA2 signaling with a peptide inhibitor effectively abrogated the metastatic process. Additionally, treatment of tumor cells with an astrocyte-conditioned medium or the chemokine CCL2 resulted in upregulation of MUC5AC expression and enhanced brain colonization. In summary, our study demonstrates that the MUC5AC/ANXA2 signaling axis promotes brain metastasis, suggesting a potential therapeutic paradigm for LUAD patients with high MUC5AC expression.

Abstract

Non-small cell lung carcinoma (NSCLC) exhibits a heightened propensity for brain metastasis, posing a significant clinical challenge. Mucin 5ac (MUC5AC) plays a pivotal role in the development of lung adenocarcinoma (LUAD); however, its role in causing brain metastases remains unknown. In this study, we aimed to investigate the contribution of MUC5AC to brain metastasis in patients with LUAD utilizing various brain metastasis models. Our findings revealed a substantial increase in the MUC5AC level in LUAD brain metastases (LUAD-BrM) samples and brain-tropic cell lines compared to primary samples or parental control cell lines. Intriguingly, depletion of MUC5AC in brain-tropic cells led to significant reductions in intracranial metastasis and tumor growth, and improved survival following intracardiac injection, in contrast to the observations in the control groups. Proteomic analysis revealed that mechanistically, MUC5AC depletion resulted in decreased expression of metastasis-associated molecules. There were increases in epithelial-to-mesenchymal transition, tumor invasiveness, and metastasis phenotypes in tumors with high MUC5AC expression. Furthermore, immunoprecipitation and proteomic analysis revealed a novel interaction of MUC5AC with Annexin A2 (ANXA2), which activated downstream matrix metalloproteases and facilitated extracellular matrix degradation to promote metastasis. Disrupting MUC5AC-ANXA2 signaling with a peptide inhibitor effectively abrogated the metastatic process. Additionally, treatment of tumor cells with an astrocyte-conditioned medium or the chemokine CCL2 resulted in upregulation of MUC5AC expression and enhanced brain colonization. In summary, our study demonstrates that the MUC5AC/ANXA2 signaling axis promotes brain metastasis, suggesting a potential therapeutic paradigm for LUAD patients with high MUC5AC expression.

참고문헌 (38)

  1. Gonzalez, H., "Cellular architecture of human brain metastases", Cell, 185, pp.729~745 (2022)
  2. Srinivasan, E. S., "The micro environment of brain metastases from solid tumors", Neurooncol. Adv, 3, pp.v121~v132 (2021)
  3. Villano, J. L., "Incidence of brain metastasis at initial presentation of lung cancer", Neuro Oncol, 17, pp.122~128 (2015)
  4. Boire, A., "Brain metastasis", Nat. Rev. Cancer, 20, pp.4~11 (2020)
  5. Nishino, M., "Brain metastases in oncogene-driven non-small cell lung cancer", Transl. Lung Cancer Res, 8, pp.S298~S307 (2019)
  6. Wang, H., "Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC : EGFR, ALK, and RET gene mutations", Cancer Med, 9, pp.487~495 (2020)
  7. Park, K., "Radiotherapy for brain metastasis and long-term survival", Sci. Rep, 11, pp.8046~ (2021)
  8. Sperduto, P. W., "Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA)", JAMA Oncol, 3, pp.827~831 (2017)
  9. Kesimer, M., "Airway mucin concentration as a marker of chronic bronchitis", New Eng. J. Med, 377, pp.911~922 (2017)
  10. Carpenter, J., "Assembly and organization of the N-terminal region of mucin MUC5AC: indications for structural and functional distinction from MUC5B", Proc. Natl Acad. Sci. USA (2021)[DOI]
  11. Song, D., "MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium", Sci. Adv, 8, pp.eabq5049~ (2022)
  12. Lakshmanan, I., "Mucins in lung cancer : diagnostic, prognostic, and ther apeutic implications", J. Thorac. Oncol, 10, pp.19~27 (2015)
  13. Lakshmanan, I., "MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling", Oncogene, 35, pp.4112~4121 (2016)
  14. Dong, Y., "MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis", Jpn. J. Clin. Oncol, 50, pp.701~711 (2020)
  15. Ning, Y., "Comprehensive analysis of the mechanism and treatment sig nificance of Mucins in lung cancer", J. Exp. Clin. Cancer Res, 39, pp.162~ (2020)
  16. Bauer, A. K., "Requirement for MUC5AC in KRAS-dependent lung carcino genesis", JCI Insight (2018)[DOI]
  17. Lakshmanan, I., "ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation", Mol. Oncol, 15, pp.1866~1881 (2021)
  18. Pothuraju, R., "Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance", Mol. Cancer, 19, pp.37~ (2020)
  19. Chaudhary, S., "Dual blockade of EGFR and CDK4", 6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring, 2021, pp.510, 79~92
  20. Chaudhary, S., "Over expression of caspase 7 is ERα dependent to affect proliferation and cell growth in breast cancer cells by targeting p21Cip", Oncogenesis, 5, pp.e219~e219 (2016)
  21. Ganguly, K., "Secretory mucin 5AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness", Cancer Res, 81, pp.91~102 (2021)
  22. Ponnusamy, M. P., "Emerging role of mucins in epithelial to mesenchymal transition", Curr. Cancer Drug Targets, 13, pp.945~956 (2013)
  23. "Distinct tumor architectures for metastatic colonization of the brain" (2023)[URL]
  24. Steeg, P. S., "Brain metastases as preventive and therapeutic targets", Nat. Rev. Cancer, 11, pp.352~363 (2011)
  25. Lin, X., "Treatment of brain metastases", J. Clin. Oncol, 33, pp.3475~3484 (2015)
  26. Fidler, I. J., "The brain micro environment and cancer metastasis", Mol. Cells, 30, pp.93~98 (2010)
  27. Massagué, J., "Metastatic colonization by circulating tumour cells", Nature, 529, pp.298~306 (2016)
  28. Quail, D. F., "The microenvironmental landscape of brain tumors", Cancer Cell, 31, pp.326~341 (2017)
  29. "The journey of cancer cells to the brain : challenges and opportunities", Int. J. Mol. Sci, 24, pp.3854~ (2023)
  30. Ramos-Castaneda, M., , TP138. TP138 Thoracic Oncology: Basic Science Advances (2021)
  31. Chaudhary, S., "Abstract 1283 : MUC5AC promotes brain metastases and colonization in non small cell lung cancer", Cancer Res, 83, pp.1283~1283 (2023)
  32. Wang, T., "Crucial role of Anxa2 in cancer progression : highlights on its novel regulatory mechanism", Cancer Biol. Med, 16, pp.671~687 (2019)
  33. Lokman, N. A., "The role of annexin A2in tumorigenesis and cancer progression", Cancer Microenviron, 4, pp.199~208 (2011)
  34. Maji, S., "Exosomal annexin II promotes angiogenesis and breast cancer metastasis", Mol. Cancer Res, 15, pp.93~105 (2017)
  35. Di Martino, J. S., "Remodeling the ECM: implica tions for metastasis and tumor dormancy", Cancers (2021)[DOI]
  36. Pein, M., "Microenvironment in metastasis : roadblocks and sup portive niches", Am. J. Physiol. Cell Physiol, 309, pp.C627~C638 (2015)
  37. Hajal, C., "The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain", Sci. Adv, 7, pp.eabg8139~ (2021)
  38. Fang, W. B., "CCL2", CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein-and p42, J. Biol. Chem, pp.2012, 287[DOI]

관련 논문AI추천

Expression of MUC1 and MUC4 and Its Prognostic Significance in Non-Small Cell Lung Carcinoma강유나, 권건영, 권선영, 김상표, 박지영, 이상숙, 이혜원, 전지민, 정혜라, 최미선, 최원일, 황일선대한병리학회 · Journal of Pathology and Translational Medicine2010 · 제44권 제4호Role of GALNT14 in lung metastasis of breast cancer김미영생화학분자생물학회 · BMB Reports2017 · 제50권 제5호Mucin in cancer: a stealth cloak for cancer cells위동한, 정연상, 차종호생화학분자생물학회 · BMB Reports2021 · 제54권 제7호GPR78 promotes lung cancer cell migration and metastasis by activation of Gαq-Rho GTPase pathwayDan-Dan Dong, Gao Li, Hui Zhou생화학분자생물학회 · BMB Reports2016 · 제49권 제11호MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection권형주, Byoung Kwon Park, Dongbum Kim, Jeong-A Park, Jinsoo Kim, Sangkyu Park, Sony Maharjan, Younghee Lee생화학분자생물학회 · BMB Reports2021 · 제54권 제8호Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with nonsmall cell lung cancerDong Bok Shin, Eun Kyung Cho, Hee Kyung Ahn, Hwa-Sun Park, Inkeun Park, Jae Hoon Lee, Jinny Park, Junshik Hong, Kyu Ree Park, Min Young Baek, Shin Myung Kang, Sun Jin Sym, Young Saing Kim대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제1호

이 간행물의 다른 논문 (218건)

Big data and deep learning for RNA biologyJeon Hyeonseong, Baek Daehyun, Hwang Hyeonseo, Yeo Nagyeongpp. 1-29RGS19 activates the MYH9/β-catenin/c-Myc positive feedback loop in hepatocellular carcinomaXu Yanan, Ke Shanjia, Lu Shounan, Bai Miaoyu, Yu Hongjun, Yin Bing, Wang Chaoqun, Feng Zhigang, Li Zihao, Huang Jingjing, Li Xinglong, Qian Baolin, Hua Yongliang, Fu Yao, Sun Bei, Wu Yaohua, Ma Yongpp. 1-14Molecular mechanisms of circular RNA translationKim Yoon Ki, Hwang Hyun Jungpp. 1-9The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolismKim Ho, Yun Hye Jin, 이종호, Lee Su Bin, Kim Seok-Ho, Park Yun-Yong, Park Su Hwan, Ju Jin-Sung, Woo Hyunmin, Győrffy Balázs, Kim Eun-jeong, Han Hee Dong, Eyun Seong-ilpp. 1-15Neuron type-specific optogenetic stimulation for differential stroke recovery in chronic capsular infarctKim Ra Gyung, Cho Jongwook, Park Ji-Young, Kim Young Ro, Lee Min-Cheol, Kim Hyoung-Ihlpp. 1-11
원문 보기